Supply Chain
Pharmaceutical companies outsourced $36.6 billion in global research and development expenses to contract drug developers in 2011, up 6.6 percent from 2009, according to healthcare research firm Kalorama Information.
The proportion of Americans reporting problems affording prescription drugs remained level between 2007 and 2010, with more than one in eight going without a prescribed drug in 2010, according to a national study released today by the Center for Studying Health System Change. Despite the flat numbers, the news isn't necessarily good.
Fujifilm Holdings Corporation announced Wednesday that it has entered into a definitive agreement to acquire ultrasound technology firm SonoSite, Inc. for approximately $995 million.
Cardinal Health, a Dublin, Ohio-based, Fortune 19, healthcare services company has been ranked in the number one spot in Gartner's third annual Healthcare Supply Chain Top 25, replacing med-surg supplier Owens & Minor, which dropped to fifth place.
Between 2010 and 2020 the overall market for chronic pain therapies will remain stable at approximately $20 billion, with treatments for back pain and arthritis predicted to be the most lucrative, according to findings from healthcare research firm Decision Resources.
The Centers for Medicare & Medicaid Services (CMS) announced Wednesday operational details for the next stage in its competitive bidding program despite ongoing opposition from patient advocacy groups, economists and 145 members of Congress.
Medical device company ArthroCare announced Monday that it has reached an agreement in principle to settle an investors' class action lawsuit pending against the company and two of its former officers for $74 million.
Hospitals are expanding services, supplies and staff training programs to meet the needs of morbidly obese patients, according to a new report from healthcare supply contracting company Novation.
Makers of medical beds used in hospitals, nursing homes and patients' homes will see their best growth come from markets outside the United States and Europe, according to healthcare market research firm Kalorama Information.
Private equity firm Ancor Capital Partners announced Tuesday that it has acquired WellSpring Pharmaceutical Corporation, a manufacturer and marketer of specialty prescription and over-the-counter products. This is Ancor's fifteenth acquisition in the healthcare segment.